Prof Suzanne Cory
Honorary (Professor Emeritus)
Department of Medical Biology (WEHI)
254 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
MNT: a new target for AML
DOI: 10.1016/j.bneo.2025.1001492024
Book Chapter
The BCL-2 oncogene regulates lymphocyte survival and potentiates lymphomagenesis
DOI: 10.1201/9781003580539-172024
Journal article
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis
DOI: 10.1158/2643-3230.BCD-23-02102023
Journal article
MYC-Alarmin Axis As a Novel Oncogenic Driver in a Subgroup of Triple Negative Myeloproliferative Neoplasms
DOI: 10.1182/blood-2023-1743832023
Journal article
MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis
DOI: 10.1038/s41418-023-01119-y2012
Journal article
Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells
DOI: 10.1182/blood-2011-12-4009292008
Journal article
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas
DOI: 10.1073/pnas.0809957105
RECENT SCHOLARLY WORKS
2022
Journal article
Joan Heath interviews Suzanne Cory and Joan Steitz: a female perspective of science in the swinging ‘60s
DOI: 10.1242/dmm.0496092021
Journal article
CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation
DOI: 10.1016/j.stemcr.2021.10.0012020
Journal article
Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis
DOI: 10.1182/blood.20190030142019
Journal article
Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice
DOI: 10.1038/s41418-018-0209-12019
Journal article
A joint odyssey into cancer genetics
DOI: 10.1146/annurev-cancerbio-030518-055543